The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Role and Mechanism of Gut Microbiota in Human Disease
Open accessAbstract
The human gut microbiome is a huge microbial community that plays an irreplaceable role in human life. With the further development of research, the influence of intestinal flora on human diseases has been gradually excavated. Gut microbiota (GM) dysbiosis has adverse health effects on the human body that will lead to a variety of chronic diseases. The underlying mechanisms of GM on human diseases are incredibly complicated. This review focuses on the regulation and mechanism of GM on neurodegenerative diseases, cardiovascular diseases, metabolic diseases and gastrointestinal diseases, thus providing a potential target for the prevention and treatment of disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zhang, L., Wang, F., Wang, J., Wang, Y., & Fang, Y. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15173 · Cited by 29
RetractedAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597 · cited 2×
“High levels of TMAO promote the migration of macrophages and accelerate the transformation of macrophages into foam cells, increasing the expression of pro-inflammatory cytokines, thereby promoting the formation of atherosclerosis (Wang et al., 2011; Koeth et al., 2013).”
BackgroundGut microbiota in human metabolic health and disease
Fan, Y., & Pedersen, O. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0433-9 · Cited by 4,724
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., Britt, E. B., Fu, X., Wu, Y., Li, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3145 · Cited by 4,386
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis
Yano, J. M., Yu, K., Donaldson, G. P., Shastri, G. G., Ann, P., Ma, L., Nagler, C. R., Ismagilov, R. F., Mazmanian, S. K., & Hsiao, E. Y. (2015) · Cell · doi:10.1016/j.cell.2015.02.047 · Cited by 3,614
The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice
Turnbaugh, P. J., Ridaura, V. K., Faith, J. J., Rey, F. E., Knight, R., & Gordon, J. I. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000322 · Cited by 3,058 · cited 1×
“Firmicutes/Bacteroidetes ratio is an important parameter to reflect GM disorder (Turnbaugh et al., 2006; Turnbaugh et al., 2009; Thaiss et al., 2016).”
BackgroundZhou, B., Bentham, J., Di Cesare, M., Bixby, H., Danaei, G., Cowan, M. J., Paciorek, C. J., Singh, G., Hajifathalian, K., Bennett, J. E., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31919-5 · Cited by 2,579
Chatterjee, S., Khunti, K., & Davies, M. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30058-2 · Cited by 2,577 · cited 1×
“T2DM is non-insulin-dependent diabetes, which is characterized by a decline in insulin secretion and insulin resistance (Chatterjee et al., 2017).”
The gut microbiota–brain axis in behaviour and brain disorders
Morais, L. H., Schreiber, H. L., & Mazmanian, S. K. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00460-0 · Cited by 2,149 · cited 1×
“These pathways may be involved in the pathogenesis of neurodegenerative diseases and other neuro related diseases (Morais et al., 2020).”
BackgroundGut microbiota-derived metabolites as key actors in inflammatory bowel disease
Lavelle, A., & Sokol, H. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0258-z · Cited by 2,015
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Zhu, W., Gregory, J. C., Org, E., Buffa, J. A., Gupta, N., Wang, Z., Li, L., Fu, X., Wu, Y., Mehrabian, M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.011 · Cited by 1,968
Murray, C. J. L., Barber, R. M., Foreman, K. J., Ozgoren, A. A., Abd-Allah, F., Abera, S. F., Aboyans, V., Abraham, J. P., Abubakar, I., Abu-Raddad, L. J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61340-x · Cited by 1,964
Self-citationKelly, C. J., Zheng, L., Campbell, E. L., Saeedi, B., Scholz, C. C., Bayless, A. J., Wilson, K. E., Glover, L. E., Kominsky, D. J., Magnuson, A., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.03.005 · Cited by 1,716
Gut microbiota dysbiosis contributes to the development of hypertension
Li, J., Zhao, F., Wang, Y., Chen, J., Tao, J., Tian, G., Wu, S., Liu, W., Cui, Q., Geng, B., et al. (2017) · Microbiome · doi:10.1186/s40168-016-0222-x · Cited by 1,685
The gut microbiome in atherosclerotic cardiovascular disease
Jie, Z., Xia, H., Zhong, S.-L., Feng, Q., Li, S., Liang, S., Zhong, H., Liu, Z., Gao, Y., Zhao, H., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00900-1 · Cited by 1,638
The interplay between the intestinal microbiota and the brain
Collins, S. M., Surette, M., & Bercik, P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2876 · Cited by 1,611 · cited 1×
“An increasing number of studies suggested that GM can modulate nervous, endocrine, and immune communication through the gut-brain axis which takes part in the occurrence and development of central nervous system diseases, especially in Parkinson disease (PD) and Alzheimer disease (AD) (Collins et al., 2012).”
BackgroundGut microbiome and serum metabolome alterations in obesity and after weight-loss intervention
Liu, R., Hong, J., Xu, X., Feng, Q., Zhang, D., Gu, Y., Shi, J., Zhao, S., Liu, W., Wang, X., et al. (2017) · Nature Medicine · doi:10.1038/nm.4358 · Cited by 1,501
Gut microbial metabolites in obesity, NAFLD and T2DM
Canfora, E. E., Meex, R. C. R., Venema, K., & Blaak, E. E. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0156-z · Cited by 1,493
Gut Dysbiosis Is Linked to Hypertension
Yang, T., Santisteban, M. M., Rodriguez, V., Li, E., Ahmari, N., Carvajal, J. M., Zadeh, M., Gong, M., Qi, Y., Zubcevic, J., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05315 · Cited by 1,478
Macia, L., Tan, J., Vieira, A. T., Leach, K., Stanley, D., Luong, S., Maruya, M., Ian McKenzie, C., Hijikata, A., Wong, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms7734 · Cited by 1,439
A unified catalog of 204,938 reference genomes from the human gut microbiome
Almeida, A., Nayfach, S., Boland, M., Strozzi, F., Beracochea, M., Shi, Z. J., Pollard, K. S., Sakharova, E., Parks, D. H., Hugenholtz, P., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-020-0603-3 · Cited by 1,367
Wang, X., Sun, G., Feng, T., Zhang, J., Huang, X., Wang, T., Xie, Z., Chu, X., Yang, J., Wang, H., et al. (2019) · Cell Research · doi:10.1038/s41422-019-0216-x · Cited by 1,144 · cited 1×
“org 3 and isolucine accumulation, control neuroinflammation, and improve cognitive impairment (Wang et al., 2019).”
BackgroundReduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
Harach, T., Marungruang, N., Duthilleul, N., Cheatham, V., Mc Coy, K. D., Frisoni, G., Neher, J. J., Fåk, F., Jucker, M., Lasser, T., et al. (2017) · Scientific Reports · doi:10.1038/srep41802 · Cited by 901
Hill‐Burns, E. M., Debelius, J. W., Morton, J. T., Wissemann, W. T., Lewis, M. R., Wallen, Z. D., Peddada, S. D., Factor, S. A., Molho, E., Zabetian, C. P., et al. (2017) · Movement Disorders · doi:10.1002/mds.26942 · Cited by 874
A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors
Nemet, I., Saha, P. P., Gupta, N., Zhu, W., Romano, K. A., Skye, S. M., Cajka, T., Mohan, M. L., Li, L., Wu, Y., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.016 · Cited by 784
Host–microbiota interactions in inflammatory bowel disease
Caruso, R., Lo, B. C., & Núñez, G. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0268-7 · Cited by 780
Li, J., Lin, S., Vanhoutte, P. M., Woo, C. W., & Xu, A. (2016) · Circulation · doi:10.1161/circulationaha.115.019645 · Cited by 775 · cited 1×
“The abundance of Enterobacteriaceae and Enterobacter aerogenes is much higher in atherosclerosis patients Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 4 than in control samples, which inhibited the growth of beneficial bacteria (Li et al., 2016; Jie et al., 2017).”
BackgroundMicrobiota-Produced Succinate Improves Glucose Homeostasis via Intestinal Gluconeogenesis
De Vadder, F., Kovatcheva-Datchary, P., Zitoun, C., Duchampt, A., Bäckhed, F., & Mithieux, G. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.013 · Cited by 754
Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
Hoyles, L., Fernández-Real, J.-M., Federici, M., Serino, M., Abbott, J., Charpentier, J., Heymes, C., Luque, J. L., Anthony, E., Barton, R. H., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0061-3 · Cited by 720
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Jiang, C., Xie, C., Li, F., Zhang, L., Nichols, R. G., Krausz, K. W., Cai, J., Qi, Y., Fang, Z.-Z., Takahashi, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76738 · Cited by 693
Raman, M., Ahmed, I., Gillevet, P. M., Probert, C. S., Ratcliffe, N. M., Smith, S., Greenwood, R., Sikaroodi, M., Lam, V., Crotty, P., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.02.015 · Cited by 672
Role of gut microbiota in atherosclerosis
Jonsson, A. L., & Bäckhed, F. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.183 · Cited by 644
Bedarf, J. R., Hildebrand, F., Coelho, L. P., Sunagawa, S., Bahram, M., Goeser, F., Bork, P., & Wüllner, U. (2017) · Genome Medicine · doi:10.1186/s13073-017-0428-y · Cited by 642
Wong, S. H., Zhao, L., Zhang, X., Nakatsu, G., Han, J., Xu, W., Xiao, X., Kwong, T. N. Y., Tsoi, H., Wu, W. K. K., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.08.022 · Cited by 634
Kim, M.-S., Kim, Y., Choi, H., Kim, W., Park, S., Lee, D., Kim, D. K., Kim, H. J., Choi, H., Hyun, D.-W., et al. (2020) · Gut · doi:10.1136/gutjnl-2018-317431 · Cited by 614
Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies
Peng, C., Gathagan, R. J., Covell, D. J., Medellin, C., Stieber, A., Robinson, J. L., Zhang, B., Pitkin, R. M., Olufemi, M. F., Luk, K. C., et al. (2018) · Nature · doi:10.1038/s41586-018-0104-4 · Cited by 605
Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity
Long, X., Wong, C. C., Tong, L., Chu, E. S. H., Ho Szeto, C., Go, M. Y. Y., Coker, O. O., Chan, A. W. H., Chan, F. K. L., Sung, J. J. Y., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0541-3 · Cited by 557
Heintz‐Buschart, A., Pandey, U., Wicke, T., Sixel‐Döring, F., Janzen, A., Sittig‐Wiegand, E., Trenkwalder, C., Oertel, W. H., Mollenhauer, B., & Wilmes, P. (2018) · Movement Disorders · doi:10.1002/mds.27105 · Cited by 554
The Gut Microbiota in Prediabetes and Diabetes: A Population-Based Cross-Sectional Study
Wu, H., Tremaroli, V., Schmidt, C., Lundqvist, A., Olsson, L. M., Krämer, M., Gummesson, A., Perkins, R., Bergström, G., & Bäckhed, F. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.011 · Cited by 528
Microbiota and host determinants of behavioural phenotype in maternally separated mice
De Palma, G., Blennerhassett, P., Lu, J., Deng, Y., Park, A. J., Green, W., Denou, E., Silva, M. A., Santacruz, A., Sanz, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms8735 · Cited by 517
Alterations of the Gut Microbiome in Hypertension
Yan, Q., Gu, Y., Li, X., Yang, W., Jia, L., Chen, C., Han, X., Huang, Y., Zhao, L., Li, P., et al. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00381 · Cited by 500
Self-citationCrusell, M. K. W., Hansen, T. H., Nielsen, T., Allin, K. H., Rühlemann, M. C., Damm, P., Vestergaard, H., Rørbye, C., Jørgensen, N. R., Christiansen, O. B., et al. (2018) · Microbiome · doi:10.1186/s40168-018-0472-x · Cited by 480
Li, X. S., Obeid, S., Klingenberg, R., Gencer, B., Mach, F., Räber, L., Windecker, S., Rodondi, N., Nanchen, D., Muller, O., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehw582 · Cited by 479
Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota
Li, B., He, Y., Ma, J., Huang, P., Du, J., Cao, L., Wang, Y., Xiao, Q., Tang, H., & Chen, S. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.07.002 · Cited by 478
Kozarov, E. V., Dorn, B. R., Shelburne, C. E., Dunn, W. A., & Progulske-Fox, A. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000155018.67835.1a · Cited by 476
Persistent microbiome alterations modulate the rate of post-dieting weight regain
Thaiss, C. A., Itav, S., Rothschild, D., Meijer, M. T., Levy, M., Moresi, C., Dohnalová, L., Braverman, S., Rozin, S., Malitsky, S., et al. (2016) · Nature · doi:10.1038/nature20796 · Cited by 471
Zheng, X., Chen, T., Jiang, R., Zhao, A., Wu, Q., Kuang, J., Sun, D., Ren, Z., Li, M., Zhao, M., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.11.017 · Cited by 458
SCFAs strongly stimulate PYY production in human enteroendocrine cells
Larraufie, P., Martin-Gallausiaux, C., Lapaque, N., Dore, J., Gribble, F. M., Reimann, F., & Blottiere, H. M. (2018) · Scientific Reports · doi:10.1038/s41598-017-18259-0 · Cited by 450
Schaubeck, M., Clavel, T., Calasan, J., Lagkouvardos, I., Haange, S. B., Jehmlich, N., Basic, M., Dupont, A., Hornef, M., Bergen, M. V., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309333 · Cited by 447
Tsoi, H., Chu, E. S. H., Zhang, X., Sheng, J., Nakatsu, G., Ng, S. C., Chan, A. W. H., Chan, F. K. L., Sung, J. J. Y., & Yu, J. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.009 · Cited by 438
Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease
Qian, Y., Yang, X., Xu, S., Wu, C., Song, Y., Qin, N., Chen, S.-D., & Xiao, Q. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.02.016 · Cited by 409
Kobayashi, Y., Sugahara, H., Shimada, K., Mitsuyama, E., Kuhara, T., Yasuoka, A., Kondo, T., Abe, K., & Xiao, J.-Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-13368-2 · Cited by 403
Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage
Fluckiger, A., Daillère, R., Sassi, M., Sixt, B. S., Liu, P., Loos, F., Richard, C., Rabu, C., Alou, M. T., Goubet, A.-G., et al. (2020) · Science · doi:10.1126/science.aax0701 · Cited by 396
Zeng, S.-L., Li, S.-Z., Xiao, P.-T., Cai, Y.-Y., Chu, C., Chen, B.-Z., Li, P., Li, J., & Liu, E.-H. (2020) · Science Advances · doi:10.1126/sciadv.aax6208 · Cited by 393
The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic
Kadosh, E., Snir-Alkalay, I., Venkatachalam, A., May, S., Lasry, A., Elyada, E., Zinger, A., Shaham, M., Vaalani, G., Mernberger, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2541-0 · Cited by 378
Gut Microbiota Promote Angiotensin II–Induced Arterial Hypertension and Vascular Dysfunction
Karbach, S. H., Schönfelder, T., Brandão, I., Wilms, E., Hörmann, N., Jäckel, S., Schüler, R., Finger, S., Knorr, M., Lagrange, J., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003698 · Cited by 378
Mollica, M. P., Mattace Raso, G., Cavaliere, G., Trinchese, G., De Filippo, C., Aceto, S., Prisco, M., Pirozzi, C., Di Guida, F., Lama, A., et al. (2017) · Diabetes · doi:10.2337/db16-0924 · Cited by 356
The gut microbiota and colon cancer
Garrett, W. S. (2019) · Science · doi:10.1126/science.aaw2367 · Cited by 355
Chu, H., Duan, Y., Yang, L., & Schnabl, B. (2019) · Gut · doi:10.1136/gutjnl-2018-316307 · Cited by 354
Effect of ethanol on lipid metabolism
You, M., & Arteel, G. E. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.037 · Cited by 354
Gut microbiota in Parkinson disease in a northern German cohort
Hopfner, F., Künstner, A., Müller, S. H., Künzel, S., Zeuner, K. E., Margraf, N. G., Deuschl, G., Baines, J. F., & Kuhlenbäumer, G. (2017) · Brain Research · doi:10.1016/j.brainres.2017.04.019 · Cited by 318
Vallianou, N., Stratigou, T., Christodoulatos, G. S., & Dalamaga, M. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00352-2 · Cited by 316
Connections between the human gut microbiome and gestational diabetes mellitus
Kuang, Y.-S., Lu, J.-H., Li, S.-H., Li, J.-H., Yuan, M.-Y., He, J.-R., Chen, N.-N., Xiao, W.-Q., Shen, S.-Y., Qiu, L., et al. (2017) · GigaScience · doi:10.1093/gigascience/gix058 · Cited by 310
Changes of colonic bacterial composition in Parkinson's disease and other neurodegenerative diseases
Gerhardt, S., & Mohajeri, M. H. (2018) · Nutrients · doi:10.3390/nu10060708 · Cited by 298
Neuro-Immune Interactions at Barrier Surfaces
Veiga-Fernandes, H., & Mucida, D. (2016) · Cell · doi:10.1016/j.cell.2016.04.041 · Cited by 292
Minter, M. R., Hinterleitner, R., Meisel, M., Zhang, C., Leone, V., Zhang, X., Oyler-Castrillo, P., Zhang, X., Musch, M. W., Shen, X., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11047-w · Cited by 292
Da Silva, H. E., Teterina, A., Comelli, E. M., Taibi, A., Arendt, B. M., Fischer, S. E., Lou, W., & Allard, J. P. (2018) · Scientific Reports · doi:10.1038/s41598-018-19753-9 · Cited by 283
Rom, O., Liu, Y., Liu, Z., Zhao, Y., Wu, J., Ghrayeb, A., Villacorta, L., Fan, Y., Chang, L., Wang, L., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz2841 · Cited by 280
Self-citationDysbiosis of Gut Fungal Microbiota is Associated With Mucosal Inflammation in Crohn’s Disease
Li, Q., Wang, C., Tang, C., He, Q., Li, N., & Li, J. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000035 · Cited by 279
Revisit gut microbiota and its impact on human health and disease
Ding, R.-X., Goh, W.-R., Wu, R.-N., Yue, X.-Q., Luo, X., Khine, W. W. T., Wu, J.-R., & Lee, Y.-K. (2019) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2018.12.012 · Cited by 268
Gut microbiota in patients with Parkinson's disease in southern China
Lin, A., Zheng, W., He, Y., Tang, W., Wei, X., He, R., Huang, W., Su, Y., Huang, Y., Zhou, H., et al. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.05.007 · Cited by 253
Microbiota-derived metabolite promotes HDAC3 activity in the gut
Wu, S.-E., Hashimoto-Hill, S., Woo, V., Eshleman, E. M., Whitt, J., Engleman, L., Karns, R., Denson, L. A., Haslam, D. B., & Alenghat, T. (2020) · Nature · doi:10.1038/s41586-020-2604-2 · Cited by 249
Bharwani, A., Mian, M. F., Surette, M. G., Bienenstock, J., & Forsythe, P. (2017) · BMC Medicine · doi:10.1186/s12916-016-0771-7 · Cited by 236 · cited 1×
“…can activate the Farnesoid X receptor (FXR) then reduce the expression of inflammatory factors on monocytes, macrophages and dendritic cells, and reduce the level of inflammation, thus inhibiting the occurrence of atherosclerosis (Wang et al., 2011; De Palma et al., 2015; Bharwani et al., 2017).”
BackgroundMancuso, C., & Santangelo, R. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.009 · Cited by 232
Aoki, R., Kamikado, K., Suda, W., Takii, H., Mikami, Y., Suganuma, N., Hattori, M., & Koga, Y. (2017) · Scientific Reports · doi:10.1038/srep43522 · Cited by 225
Hasain, Z., Mokhtar, N. M., Kamaruddin, N. A., Mohamed Ismail, N. A., Razalli, N. H., Gnanou, J. V., & Raja Ali, R. A. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00188 · Cited by 225
Toral, M., Robles-Vera, I., de la Visitación, N., Romero, M., Yang, T., Sánchez, M., Gómez-Guzmán, M., Jiménez, R., Raizada, M. K., & Duarte, J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00231 · Cited by 223
Sanchez-Rodriguez, E., Egea-Zorrilla, A., Plaza-Díaz, J., Aragón-Vela, J., Muñoz-Quezada, S., Tercedor-Sánchez, L., & Abadia-Molina, F. (2020) · Nutrients · doi:10.3390/nu12030605 · Cited by 214
Chen, C., Ahn, E. H., Kang, S. S., Liu, X., Alam, A., & Ye, K. (2020) · Science Advances · doi:10.1126/sciadv.aba0466 · Cited by 205 · cited 1×
“Further studies showed that the prebiotic R13 can inhibit this pathway by enriching specific probiotics and suppresses amyloid aggregates in the gut (Chen et al., 2020).”
BackgroundGut microbiota in atherosclerosis: focus on trimethylamine N‐oxide
Zhu, Y., Li, Q., & Jiang, H. (2020) · APMIS · doi:10.1111/apm.13038 · Cited by 196
Implication of the gut microbiome composition of type 2 diabetic patients from northern China
Li, Q., Chang, Y., Zhang, K., Chen, H., Tao, S., & Zhang, Z. (2020) · Scientific Reports · doi:10.1038/s41598-020-62224-3 · Cited by 192
Skye, S. M., Zhu, W., Romano, K. A., Guo, C.-J., Wang, Z., Jia, X., Kirsop, J., Haag, B., Lang, J. M., DiDonato, J. A., et al. (2018) · Circulation Research · doi:10.1161/circresaha.118.313142 · Cited by 189
Gut Microbiota Differs Between Parkinson’s Disease Patients and Healthy Controls in Northeast China
Li, C., Cui, L., Yang, Y., Miao, J., Zhao, X., Zhang, J., Cui, G., & Zhang, Y. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00171 · Cited by 178
Brown, K., Godovannyi, A., Ma, C., Zhang, Y., Ahmadi-Vand, Z., Dai, C., Gorzelak, M. A., Chan, Y., Chan, J. M., Lochner, A., et al. (2016) · The ISME Journal · doi:10.1038/ismej.2015.114 · Cited by 174
Implications of the Gut Microbiome in Parkinson's Disease
Elfil, M., Kamel, S., Kandil, M. A., Koo, B. B., & Schaefer, S. M. (2020) · Movement Disorders · doi:10.1002/mds.28004 · Cited by 171
Time for food: The impact of diet on gut microbiota and human health
Zhang, N., Ju, Z., & Zuo, T. (2018) · Nutrition · doi:10.1016/j.nut.2017.12.005 · Cited by 165
Nie, J., Xie, L., Zhao, B.-X., Li, Y., Qiu, B., Zhu, F., Li, G.-F., He, M., Wang, Y., Wang, B., et al. (2018) · Stroke · doi:10.1161/strokeaha.118.021997 · Cited by 163
Colorectal cancer occurrence and treatment based on changes in intestinal flora
Si, H., Yang, Q., Hu, H., Ding, C., Wang, H., & Lin, X. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.05.004 · Cited by 160
Xu, J., Lai, K. K. Y., Verlinsky, A., Lugea, A., French, S. W., Cooper, M. P., Ji, C., & Tsukamoto, H. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.12.034 · Cited by 159
Microbial Metabolites Determine Host Health and the Status of Some Diseases
Sittipo, P., Shim, J., & Lee, Y. K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215296 · Cited by 157
Microbiota-modulated CART + enteric neurons autonomously regulate blood glucose
Muller, P. A., Matheis, F., Schneeberger, M., Kerner, Z., Jové, V., & Mucida, D. (2020) · Science · doi:10.1126/science.abd6176 · Cited by 154
Interaction of Hydrogen Sulfide with Nitric Oxide in the Cardiovascular System
Nagpure, B. V., & Bian, J. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/6904327 · Cited by 151
Molecular Pathology of Lewy Body Diseases
Beyer, K., Domingo-Sàbat, M., & Ariza, A. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10030724 · Cited by 145
De Munck, T. J. I., Xu, P., Verwijs, H. J. A., Masclee, A. A. M., Jonkers, D., Verbeek, J., & Koek, G. H. (2020) · Liver International · doi:10.1111/liv.14696 · Cited by 145
Zhou, H., Sun, L., Zhang, S., Zhao, X. Y., Gang, X., & Wang, G. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00125 · Cited by 144
Chou, R., Chen, C., Chen, I., Huang, H.-L., Lu, Y., Kuo, C., Chang, C., Huang, P., Chen, J., & Lin, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-40638-y · Cited by 141
Antihypertensive Effects of Probiotics
Robles‐Vera, I., Toral, M., Romero, M., Jiménez, R., Sánchez, M., Pérez‐Vizcaíno, F., & Duarte, J. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0723-4 · Cited by 139
Potential Influences of Gut Microbiota on the Formation of Intracranial Aneurysm
Shikata, F., Shimada, K., Sato, H., Ikedo, T., Kuwabara, A., Furukawa, H., Korai, M., Kotoda, M., Yokosuka, K., Makino, H., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.11804 · Cited by 135
Del Bo', C., Bernardi, S., Cherubini, A., Porrini, M., Gargari, G., Hidalgo-Liberona, N., González-Domínguez, R., Zamora-Ros, R., Peron, G., Marino, M., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2020.12.014 · Cited by 133
In silico analyses of metagenomes from human atherosclerotic plaque samples
Mitra, S., Drautz‐Moses, D. I., Alhede, M., Maw, M. T., Liu, Y., Purbojati, R. W., Yap, Z. H., Kushwaha, K. K., Gheorghe, A., Bjarnsholt, T., et al. (2015) · Microbiome · doi:10.1186/s40168-015-0100-y · Cited by 133
Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases
Meng, G., Ma, Y., Xie, L., Ferro, A., & Ji, Y. H. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12900 · Cited by 132
Zubcevic, J. A., Richards, E. M., Yang, T., Kim, S., Sumners, C., Pepine, C. J., & Raizada, M. K. (2019) · Circulation Research · doi:10.1161/circresaha.119.313965 · Cited by 129
Eftychi, C., Schwarzer, R., Vlantis, K., Wachsmuth, L., Basic, M., Wagle, P., Neurath, M. F., Becker, C., Bleich, A., & Pasparakis, M. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.008 · Cited by 129
de la Cuesta‐Zuluaga, J., Corrales-Agudelo, V., Velásquez-Mejía, E. P., Carmona, J. A., Abad, J. M., & Escobar, J. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-29687-x · Cited by 116
From role of gut microbiota to microbial-based therapies in type 2-diabetes
Leylabadlo, H. E., Sanaie, S., Heravi, F. S., Ahmadian, Z., & Ghotaslou, R. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104268 · Cited by 100
Kim, Y., Seok, S., Zhang, Y., Ma, J., Kong, B., Guo, G. L., KEMPER, B. W., & Kemper, J. K. (2020) · Nature Communications · doi:10.1038/s41467-020-19803-9 · Cited by 93
Prevention of Gestational Diabetes Mellitus (GDM) and Probiotics: Mechanism of Action: A Review
Rad, A. H., Bagheri, N., Mohammad‐Alizadeh‐Charandabi, S., Kashani, N., Mobaraki-Asl, N., Mirghafurvand, M., Asgharian, H., Ansari, F., & Pourjafar, H. (2019) · Current Diabetes Reviews · doi:10.2174/1573399815666190712193828 · Cited by 91
Are infections seeding some cases of Alzheimer’s disease?
Abbott, A. (2020) · Nature · doi:10.1038/d41586-020-03084-9 · Cited by 91
Bile Acids Increase Independently From Hypocaloric Restriction After Bariatric Surgery
Jahansouz, C., Xu, H., Hertzel, A. V., Serrot, F. J., Kvalheim, N., Cole, A. J., Abraham, A. A., Luthra, G., Ewing, K., Leslie, D. B., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001552 · Cited by 89
The Genetic Contribution to Type 1 Diabetes
Bakay, M. A., Pandey, R., Grant, S. F. A., & Hakonarson, H. H. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1235-1 · Cited by 80
Zhou, H., Zhao, X. Y., Sun, L., Liu, Y., Lv, Y., Gang, X., & Wang, G. (2020) · Disease Markers · doi:10.1155/2020/3936247 · Cited by 65
Farhangi, M. A., & Vajdi, M. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuaa111 · Cited by 54
Obstructive Sleep Apnea-Induced Hypertension: Role of the Gut Microbiota
Durgan, D. J. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0732-3 · Cited by 47
A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression
Iruzubieta, P., Medina, J. M., Fernández-López, R., Crespo, J., & de la Cruz, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051369 · Cited by 46
Increase in clinically recorded type 2 diabetes after colectomy
Jensen, A. B., Sørensen, T. I. A., Pedersen, O. B., Jess, T., Brunak, S., & Allin, K. H. (2018) · eLife · doi:10.7554/elife.37420 · Cited by 45
Ayaz, B. D., & Zubcevic, J. A. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104677 · Cited by 45
[Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease].
Wang, W., Shi, L., Shi, L., & Xu, L. (2018) · PubMed · doi:10.3760/cma.j.issn.0578-1426.2018.02.004 · Cited by 38
Tischmann, L., Drummen, M., Gatta‐Cherifi, B., Raben, A., Fogelholm, M., Hartmann, B., Holst, J. J., Matias, I., Cota, D., Mensink, R. P., et al. (2019) · Nutrients · doi:10.3390/nu11102269 · Cited by 27
The H1 Haplotype of the Tau Gene (MAPT) is Associated with Mild Cognitive Impairment
Maria, E. D., Cammarata, S., Parodi, M. I., Borghi, R., Benussi, L., Galli, M., Galimberti, D., Ghidoni, R., Gonella, D., Novello, C., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1285 · Cited by 24
Pan, W. Q., Zhang, Y., Zeng, C., Xu, F. L., Yan, J., & Weng, J. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6453 · Cited by 23
Gut Microbiota and Heart, Vascular Injury
Zeng, C., & Tan, H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2385-4_8 · Cited by 21
Miao, Z., Lin, J.-S., Mao, Y., Chen, G., Zeng, F., Dong, H., Jiang, Z., Wang, J., Xiao, C., Shuai, M., et al. (2020) · Current Developments in Nutrition · doi:10.1093/cdn/nzaa061_080 · Cited by 7
Self-citationHaghikia, A., Liman, T., Li, X., Schmidt, D., Zimmermann, F., Kraenkel, N., Fraccarollo, D., Widera, C., Sonnenschein, K., Haghikia, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy565.p2467 · Cited by 2
Cited by
Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis
Rusch, J. A., Layden, B. T., & Dugas, L. R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1130689 · Cited by 415
Microbiota medicine: towards clinical revolution
Gebrayel, P., Nicco, C., Al Khodor, S., Bilinski, J., Caselli, E., Comelli, E. M., Egert, M., Giaroni, C., Karpinski, T. M., Loniewski, I., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03296-9 · Cited by 276
Chen, Y.-K., Liu, T.-T., Teia, F. K. F., & Xie, M.-Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1218880 · Cited by 74
Self-citationShort-chain fatty acids: Important components of the gut-brain axis against AD
Huang, Y., Wang, Y. F., Miao, J., Zheng, R. F., & Li, J. Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116601 · Cited by 70
Shimizu, Y., Yamamura, R., Yokoi, Y., Ayabe, T., Ukawa, S., Nakamura, K., Okada, E., Imae, A., Nakagawa, T., Tamakoshi, A., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2190306 · Cited by 53
“On the other hand, an imbalance of the intestinal microbiota, dysbiosis is involved in various diseases such as inflammatory bowel diseases, hypertension, arteriosclerosis, cancer, diabetes, autism, and depression.(14,15) Recently, it has been reported that the intestinal microbiota composition relates to sleep qualit…”
Background
Metadata
- Authors
- Chen, Y., Zhou, J., & Wang, L.
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2021-03-17
- Volume
- 11
- Pages
- 625913-625913
- ISSN
- 2235-2988 (ISSN-L)
- OpenAlex
- W3136819994
- Cited by
- 627
- References
- 126
- FWCI
- 26.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.